AltaValve Early Feasibility Study Protocol

NAUnknownINTERVENTIONAL
Enrollment

15

Participants

Timeline

Start Date

December 4, 2019

Primary Completion Date

September 30, 2025

Study Completion Date

September 30, 2025

Conditions
Mitral RegurgitationMitral InsufficiencyMitral Valve IncompetenceMitral Valve RegurgitationMitral Incompetence
Interventions
DEVICE

AltaValve

Transcatheter Mitral Valve Replacement

Trial Locations (12)

20010

RECRUITING

MedStar Washington Hospital, Washington D.C.

28203

RECRUITING

Atrium Health, Charlotte

30308

RECRUITING

Emory University, Atlanta

33606

RECRUITING

Tampa General Hospital, Tampa

38120

RECRUITING

Baptist Memorial Hospital - Memphis, Memphis

70360

RECRUITING

Cardiovascular Institute of the South, Houma

73135

RECRUITING

Oklahoma Heart Hospital, Oklahoma City

75093

RECRUITING

Baylor Scott & White, Plano

77030

RECRUITING

Houston Methodist Hospital, Houston

85712

RECRUITING

Tucson Medical Center, Tucson

91360

RECRUITING

Los Robles Regional Medical Center, Thousand Oaks

07960

RECRUITING

Morristown Medical Center, Morristown

Sponsors
All Listed Sponsors
lead

4C Medical Technologies, Inc.

INDUSTRY

NCT03997305 - AltaValve Early Feasibility Study Protocol | Biotech Hunter | Biotech Hunter